We highly value your continued support of DRG products and services. In the context of improving our overall customer satisfaction and providing you with compelling and exciting new products, we invite you to complete this short questionnaire.
I would like to confirm that all survey responses and feedback will be kept confidential and may be completed anonymously.
Thank you very much for your cooperation!
Eric van Bladel, COO
News and Updates
NEW AMH (Anti-Mullerian Hormone) ELISA Available at DRG!
DRG is proud to announce a new AMH ELISA (EIA-6053), a quantitative and sensitive ELISA for the measurement of Anti Müllerian Hormone. AMH testing by Disease State Primary ovarian insufficiency Neonatal gender determination Cryptorchidism Testicular...
read more
DRG SUCCESSFULLY EXHIBITS AT MEDLAB DUBAI 2018!
The DRG Group recently exhibited at the largest healthcare exhibition & congress in the Middle East: MEDLAB DUBAI from February 5 - 8, 2018 with great success! In addition to the presentation of several new assays DRG offered live demonstrations of our...
read more
DRG distributor “SERION-BRAZIL” successfully attends Brazilian Laboratory Medicine Exhibition in Sao Paulo, Brazil
DRG is proud to announce the new partnership with Serion-Brazil and looks forward to a longstanding and successful business relationship! Mr. Gustavo Ruales, DRG International's Latin American Sales Manager, also attended the exhibition to support...
read moreSign Up for Our Newsletter
Click the link to learn more about how DRG is certified in the manufacturing and distribution of in-vitro diagnostic reagents used in the diagnosis of autoimmune status, cancer, cardiac markers, disease status, fertility testing, pregnancy testing, diabetes and immune status.
Click the link to learn more about how DRG is certified in the manufacturing and distribution of in-vitro diagnostic reagents used in the diagnosis of autoimmune status, cancer, cardiac markers, disease status, fertility testing, pregnancy testing, diabetes and immune status.